Class II · Moderate risk
Belsomra (suvorexant)
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
National Drug Code
Is NDC 0006-0033-30 recalled?
Belsomra · 3 CASE in 1 CARTON (0006-0033-30) / 1 BLISTER PACK in 1 CASE (0006-0033-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
Yes — this exact package was recalled
2 FDA recalls name the code 0006-0033-30 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
1 of these recalls is still ongoing.
- Active ingredient
- suvorexant
- Strength
- SUVOREXANT 10 mg/1
- Form
- Tablet, Film Coated · Oral
- Labeler
- Merck Sharp & Dohme LLC
- Type
- Human Prescription Drug · DEA CIV
- Product code
- 0006-0033
Recalls naming this package
Class II · Moderate risk
Belsomra (suvorexant)
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.